ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts18182020
Avg. Estimate1.321.335.67.13
Low Estimate1.231.225.426.46
High Estimate1.461.656.058.72
Year Ago EPS1.231.264.625.6
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts17172020
Avg. Estimate864.45M885.77M3.52B4.09B
Low Estimate832M828M3.42B3.92B
High Estimate887M925M3.59B4.33B
Year Ago Sales799.11M831M3.08B3.52B
Sales Growth (year/est)8.20%6.60%14.30%16.10%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.1.171.251.231.26
EPS Actual1.231.261.381.56
Difference0.060.010.150.3
Surprise %5.10%0.80%12.20%23.80%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate1.321.335.67.13
7 Days Ago1.331.335.67.13
30 Days Ago1.341.345.627.13
60 Days Ago1.341.335.66.99
90 Days Ago1.331.375.326.58
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/A1N/A1
Up Last 30 Days1511
Down Last 30 Days1N/A12
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesALXNIndustrySectorS&P 500
Current Qtr.7.30%N/AN/A0.15
Next Qtr.5.60%N/AN/A0.27
Current Year21.20%N/AN/A0.07
Next Year27.30%N/AN/A0.12
Next 5 Years (per annum)18.91%N/AN/A0.10
Past 5 Years (per annum)19.75%N/AN/AN/A